Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Actinic Keratosis of Face and Scalp”

51 trials

Showing 20 of 51 results

Early research (Phase 1)Study completedNCT01836367
What this trial is testing

Ingenol Mebutate 0.015% Gel in the Treatment of Actinic Keratoses (AK) on the Face and Scalp

Who this might be right for
Actinic Keratosis
Icahn School of Medicine at Mount Sinai 20
Not applicableStudy completedNCT02674048
What this trial is testing

Metvix Daylight PDT in Actinic Keratosis

Who this might be right for
Actinic Keratosis
Galderma R&D 406
Post-approval studies (Phase 4)Study completedNCT02716714
What this trial is testing

Clinical Trial of Ingenol Mebutate Gel 0.015% & 0.05% in Actinic Keratosis

Who this might be right for
Actinic Keratosis
Korea University 77
Large-scale testing (Phase 3)Study completedNCT02611804
What this trial is testing

A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp

Who this might be right for
Actinic Keratosis
Teva Pharmaceuticals USA 492
Large-scale testing (Phase 3)Study completedNCT00915551
What this trial is testing

A Multi-Center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)

Who this might be right for
Actinic Keratosis
Peplin 278
Post-approval studies (Phase 4)Study completedNCT03511326
What this trial is testing

PRO With Luxerm® in the Field Treatment of Thin and Non-hyperkeratotic Non-pigmented AK

Who this might be right for
Actinic Keratoses
Galderma R&D 50
Post-approval studies (Phase 4)Study completedNCT01453179
What this trial is testing

Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2)

Who this might be right for
Actinic Keratosis
MEDA Pharma GmbH & Co. KG 221
Post-approval studies (Phase 4)Study completedNCT01926496
What this trial is testing

Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%

Who this might be right for
Actinic Keratosis (AK)
LEO Pharma 485
Large-scale testing (Phase 3)Ended earlyNCT03115476
What this trial is testing

A Trial to Compare the Incidence of Squamous Cell Carcinoma (SCC) and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp

Who this might be right for
Actinic KeratosisSquamous Cell Carcinoma
LEO Pharma 563
Large-scale testing (Phase 3)Study completedNCT03285490
What this trial is testing

A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004)

Who this might be right for
Actinic Keratosis
Almirall, S.A. 351
Large-scale testing (Phase 3)Study completedNCT00306800
What this trial is testing

Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp

Who this might be right for
Actinic Keratosis
Galderma R&D 80
Not applicableStudy completedNCT01502020
What this trial is testing

A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses

Who this might be right for
Actinic Keratoses
Actavis Mid-Atlantic LLC 410
Large-scale testing (Phase 3)Study completedNCT00916006
What this trial is testing

A Multi-center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)

Who this might be right for
Actinic Keratosis
Peplin 269
Large-scale testing (Phase 3)Study completedNCT03200912
What this trial is testing

An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic Keratosis

Who this might be right for
ACTINIC KERATOSIS
Actavis Inc. 507
Testing effectiveness (Phase 2)Study completedNCT02305888
What this trial is testing

Safety of LEO 43204 for Actinic Keratosis Applied on Face/Chest, Scalp and Trunk/Extremities, Respectively

Who this might be right for
Actinic Keratosis
LEO Pharma 189
Post-approval studies (Phase 4)Study completedNCT00777127
What this trial is testing

Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses

Who this might be right for
Actinic Keratosis
MEDA Pharma GmbH & Co. KG 258
Large-scale testing (Phase 3)Looking for participantsNCT07137819
What this trial is testing

Phase 3 - Evaluation of Veregen® 10% Ointment as New Herbal Topical Treatment for Actinic Keratosis

Who this might be right for
Actinic Keratosis of Face and Scalp
Aresus Pharma GmbH 280
Large-scale testing (Phase 3)WithdrawnNCT03024060
What this trial is testing

Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp

Who this might be right for
Actinic Keratosis
DUSA Pharmaceuticals, Inc.
Early research (Phase 1)Study completedNCT02124239
What this trial is testing

Pharmacokinetics of Ingenol Mebutate Gel in Actinic Keratosis Under Maximum Use Conditions

Who this might be right for
Actinic Keratosis
LEO Pharma 79
Early research (Phase 1)Study completedNCT02248298
What this trial is testing

Efficacy of AFL-assisted PDT With Short Incubation Time in Actinic Keratosis

Who this might be right for
Actinic Keratosis
Dong-A University 93
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation